TuisFOLD • NASDAQ
add
Amicus Therapeutics, Inc.
Vorige sluiting
$5,69
Dagwisseling
$5,65 - $5,92
Jaarwisseling
$5,51 - $12,65
Markkapitalisasie
1,79 mjd USD
Gemiddelde volume
5,03 m
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Mrt. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 125,25 m | 13,45% |
Bedryfskoste | 121,50 m | 2,52% |
Netto inkomste | -21,69 m | 55,21% |
Netto winsgrens | -17,31 | 60,53% |
Wins per aandeel | 0,03 | 250,00% |
EBITDA | -6,12 m | 68,68% |
Effektiewe belastingkoers | -20,18% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Mrt. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 250,57 m | 4,58% |
Totale bates | 789,84 m | 9,43% |
Totale aanspreeklikheid | 596,28 m | 0,88% |
Totale ekwiteit | 193,56 m | — |
Uitstaande aandele | 307,93 m | — |
Prys om te bespreek | 9,03 | — |
Opbrengs op bates | -2,52% | — |
Opbrengs op kapitaal | -3,12% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Mrt. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | -21,69 m | 55,21% |
Kontant van bedrywe | 7,76 m | 126,13% |
Kontant van beleggings | -32,86 m | -536,00% |
Kontant van finansiering | -11,70 m | 12,09% |
Netto kontantverandering | -31,98 m | 14,21% |
Beskikbare kontantvloei | 13,92 m | 239,87% |
Meer oor
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, PA. The company went public in 2007 under the NASDAQ trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates. Wikipedia
Gestig
04 Feb. 2002
Webwerf
Werknemers
499
